Palisade Bio (PALI) Receivables (2011 - 2023)
Palisade Bio (PALI) reported Receivables of $300000.0 for Q1 2023, up 112.39% on a QoQ basis from $141250.0 in Q4 2022.
Palisade Bio (PALI) has 13 years of Receivables data on file, last reported at $300000.0 in Q1 2023.
- Quarterly Receivables changed N/A year-over-year to $300000.0 in Q1 2023, while the trailing twelve-month figure through Mar 2023 was $300000.0 (changed N/A YoY) and the FY2022 annual result came in at $141250.0, changed N/A from the prior year.
- Receivables rose to $300000.0 in Q1 2023 per PALI's latest filing, from $141250.0 in the prior quarter.
- Across five years, Receivables topped out at $466782.0 in Q1 2019 and bottomed at $21064.0 in Q4 2019.
- The 5-year median for Receivables is $246976.0 (2020), against an average of $226845.4.
- The widest annual swing landed in 2019, when Receivables tumbled 94.12%; it then jumped 1267.26% in 2020.
- Tracing PALI's Receivables over 5 years: stood at $21064.0 in 2019, then jumped by 1267.26% to $288000.0 in 2020, then slumped by 79.51% to $59000.0 in 2021, then surged by 139.41% to $141250.0 in 2022, then jumped by 112.39% to $300000.0 in 2023.
- Per Business Quant, the three latest PALI Receivables figures stand at $300000.0 (Q1 2023), $141250.0 (Q4 2022), and $59000.0 (Q2 2021).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 13.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 4.15 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 2.00 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 5.73 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 883.96 Mn |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 300,000.00 |
| Dec 31, 2022 | 141,250.00 |
| Jun 30, 2021 | 59,000.00 |
| Mar 31, 2021 | 25,259.00 |
| Dec 31, 2020 | 288,000.00 |
| Sep 30, 2020 | 237,779.00 |
| Jun 30, 2020 | 245,938.00 |
| Mar 31, 2020 | 248,014.00 |
| Dec 31, 2019 | 21,064.00 |
| Sep 30, 2019 | 290,154.00 |
| Jun 30, 2019 | 398,905.00 |
| Mar 31, 2019 | 466,782.00 |
| Dec 31, 2018 | 357,995.00 |
| Sep 30, 2018 | 224,227.00 |
| Jun 30, 2018 | 478,722.00 |
| Mar 31, 2018 | 137,372.00 |
| Dec 31, 2017 | 371,586.00 |
| Sep 30, 2017 | 94,749.00 |
| Jun 30, 2017 | 563,345.00 |
| Mar 31, 2017 | 572,715.00 |
| Dec 31, 2016 | 63,572.00 |
| Sep 30, 2016 | 64,418.00 |
| Jun 30, 2016 | 5,085.00 |
| Mar 31, 2016 | 39,167.00 |
| Dec 31, 2015 | 37,316.00 |
| Sep 30, 2015 | 19,159.00 |
| Jun 30, 2015 | 18,818.00 |
| Mar 31, 2015 | 8,173.00 |
| Dec 31, 2014 | 225,524.00 |
| Sep 30, 2014 | 32,761.00 |
| Jun 30, 2014 | 24,468.00 |
| Mar 31, 2014 | 11,359.00 |
| Dec 31, 2013 | 10,000.00 |
| Sep 30, 2013 | 7,500.00 |
| Jun 30, 2013 | 56,755.00 |
| Mar 31, 2013 | 104,255.00 |
| Dec 31, 2012 | 3,333.00 |
| Sep 30, 2012 | 833.00 |
| Jun 30, 2012 | 56,930.00 |
| Mar 31, 2012 | 234,375.00 |
| Dec 31, 2011 | 234,375.00 |